EFFECT OF FOOD ON THE PHARMACOKINETICS OF LU AA21004 IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Wang, Y. [1 ]
Wojtkowski, T. [1 ]
Agyemang, A. [2 ]
Homery, M-C [3 ]
Karim, A. [1 ]
机构：
[1] Takeda Global Res & Dev Ctr, Lake Forest, IL USA
[2] Takeda Global Res & Dev Ctr Europe, London, England
[3] Biotrial, Rennes, France
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2009年 / 49卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
106
引用
收藏
页码：1115 / 1115
页数：1
相关论文
共 50 条
  • [21] Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats
    Mork, Arne
    Montezinho, Liliana P.
    Miller, Silke
    Trippodi-Murphy, Crista
    Plath, Niels
    Li, Yan
    Gulinello, Maria
    Sanchez, Connie
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2013, 105 : 41 - 50
  • [22] Impact of the Multimodal Antidepressant Lu AA21004 on Serotonin Transmission in the Rat Hippocampus
    Lecours, Maurice
    El Mansari, Mostafa
    Blier, Pierre
    BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 301S - 301S
  • [23] Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant
    Grace Chen
    Ronald Lee
    Astrid-Maria Højer
    Jeppe Klint Buchbjerg
    Michael Serenko
    Zhen Zhao
    Clinical Drug Investigation, 2013, 33 : 727 - 736
  • [24] Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant
    Chen, Grace
    Lee, Ronald
    Hojer, Astrid-Maria
    Buchbjerg, Jeppe Klint
    Serenko, Michael
    Zhao, Zhen
    CLINICAL DRUG INVESTIGATION, 2013, 33 (10) : 727 - 736
  • [25] Occupancy of the Serotonin Transporter after Administration of Lu AA21004 and its Relation to Plasma Concentration in Healthy Subjects
    Areberg, Johan
    Luntang-Jensen, Michael
    Sogaard, Birgitte
    Nilausen, Dorrit O.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 110 (04) : 401 - 404
  • [26] ABSORPTION, METABOLISM, AND EXCRETION OF AN ORAL DOSE OF [14C]-LU AA21004 50 MG IN HEALTHY MEN
    Nilauseu, D.
    Hojer, A-M
    Bendahl, L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1113 - 1113
  • [27] The effects of 10 mg Lu AA21004 and 30 mg mirtazapine on actual driving performance in healthy subjects
    Theunissen, E.
    Hojer, A. M.
    Ramaekers, J.
    Street, D.
    van Oers, A.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2011, 15 : 38 - 39
  • [28] EVALUATION OF THE SINGLE-DOSE PHARMACOKINETICS OF LU AA21004 AND ITS METABOLITES IN SUBJECTS WITH AND WITHOUT HEPATIC IMPAIRMENT.
    Wang, Y.
    Munsaka, M.
    Serenko, M.
    Tyler, D.
    Nomikos, G.
    Karim, A.
    Preston, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S71 - S71
  • [29] 5HT1A AGONIST ACTIVITY AND THE ANTIDEPRESSANT EFFICACY OF LU AA21004
    Mayze, T.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [30] ASSESSMENT OF THE CYP2C19 INTERACTION POTENTIAL OF LU AA21004
    Buchbjerg, Jeppe Klint
    Hojer, Astrid-Maria
    Jensen, Klaus Gjervig
    Sogaard, Birgitte
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1119 - 1119
12345